DIA18: CRISPR, AI, blockchain and the future of drug development

DIA18: CRISPR, AI, blockchain and the future of drug development

Source: 
Biopharma Dive
snippet: 

The Drug Information Association's annual conference wraps up Thursday, capping off a five-day whirlwind of demonstrations, panels and roundtables focused on drug development.